Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
2008
A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
2010
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
2018
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
2010
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Parkinson disease
2017 Standout
Structure and function of the spleen
2005 Standout
Rheumatoid arthritis
2018 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Non-random peroxidation of different classes of membrane phospholipids in live cells detected by metabolically integrated cis-parinaric acid
1996
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
2014 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Clinical consequences of red cell storage in the critically ill
2006
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Chemoreception in the context of the general biology of ROS
2007
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review
1998
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
2013
Osteoporosis: now and the future
2011 Standout
Recent advances in mRNA vaccine technology
2020 StandoutNobel
IL-6 as a keystone cytokine in health and disease
2015 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
2015 StandoutNobel
Biological roles of glycans
2016 Standout
Asthma
2017 Standout
Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
2011
A New Class of Easily Obtained Carbonate-Relatedμ3-Ligands and a Protein-Sized Doughnut-Shaped Coordination Oligomer
2000 StandoutNobel
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics☆
2009
Glycosylation as a strategy to improve antibody-based therapeutics
2009
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma
2016
Luminescent metal–organic frameworks
2009 Standout
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
2008
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
2014
The clinical consequences of the red cell storage lesion
2001
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
2020
mRNA transcript therapy
2014 StandoutNobel
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
2013 Standout
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases
2017
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Chemical control of phospholipid distribution across bilayer membranes
2002
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
2005
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
2016
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
ROS Signaling in Systemic and Cellular Responses to Chronic Intermittent Hypoxia
2007 StandoutNobel
Models for Arginine−Metal Binding. Synthesis of Guanidine and Urea Ligands through Amination and Hydration of a Cyanamide Ligand Bound to Platinum(II), Osmium(III), and Cobalt(III)
1997 Nobel
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Probing d8−d8 Interactions in Luminescent Mono- and Binuclear Cyclometalated Platinum(II) Complexes of 6-Phenyl-2,2‘-bipyridines
1999
Supramolecular Coordination: Self-Assembly of Finite Two- and Three-Dimensional Ensembles
2011 Standout
Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis
1997
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Square-Planar Pd(II), Pt(II), and Au(III) Terpyridine Complexes: Their Syntheses, Physical Properties, Supramolecular Constructs, and Biomedical Activities
2008
Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD
2007
Alkali-metal guanidinates: solid-state structural diversity in solvent-free derivatives
1999
Additions to Metal-Activated Organonitriles
2002 Standout
White Organic Light‐Emitting Devices for Solid‐State Lighting
2004 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Catalysis in Ionic Liquids
2007 Standout
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Spectroelectrochemistry and Dimerization Equilibria of Chloro(terpyridine)platinum(II). Nature of the Reduced Complexes
1996
4,4″‐Disubstituted Terpyridines and Their Homoleptic FeII Complexes
2013 StandoutNobel
Guanidine Is a Zn2+-Binding Ligand at Neutral pH in Aqueous Solution
2002
Works of Michael Moxness being referenced
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
2008
Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
2007
Immunogenicity Testing by Electrochemiluminescent Detection for Antibodies Directed against Therapeutic Human Monoclonal Antibodies
2005
Hydrogen Peroxide Oxidation Induces the Transfer of Phospholipids from the Membrane into the Cytosol of Human Erythrocytes
1994
Development of a Maturing T-Cell-Mediated Immune Response in Patients with Idiopathic Parkinson’s Disease Receiving r-metHuGDNF Via Continuous Intraputaminal Infusion
2007
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
2008
A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab
2016
Terminal and new bridging coordination of methylguanidine, arginine, and canavanine to platinum(II). The first crystallographic study of bonding between a transition metal and a guanidine ligand
1990
Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics
2010
Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
2007
Hemoglobin Oxidation Products Extract Phospholipids from the Membrane of Human Erythrocytes
1996